+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gingivitis Drug"

Gingivitis - Pipeline Insight, 2024 - Product Thumbnail Image

Gingivitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Gingivitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Gingivitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 40 Pages
  • Global
From
Gingivitis Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Gingivitis Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • February 2020
  • 228 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Gingivitis is a common form of gum disease caused by the buildup of plaque on the teeth. It is characterized by red, swollen, and bleeding gums. Gingivitis is typically treated with a combination of professional dental cleaning and good oral hygiene. Pharmaceuticals play an important role in the treatment of gingivitis, with a variety of drugs available to help reduce inflammation and prevent further damage to the gums. Common gingivitis drugs include antibiotics, antiseptics, and anti-inflammatory medications. Antibiotics are used to reduce the number of bacteria in the mouth, while antiseptics help to reduce inflammation and prevent further infection. Anti-inflammatory medications help to reduce swelling and pain associated with gingivitis. Some of the companies in the gingivitis drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies produce a variety of drugs to treat gingivitis, including antibiotics, antiseptics, and anti-inflammatory medications. Show Less Read more